Amber Newman
Family · Manning, SCNPI 1467933861
Payments from drug & device makers
Across 136 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$545
- AbbVie$490
- Amgen$160
- Novartis$160
- Novo Nordisk$156
- Merck$123
- plus $973 from 21 others
What the payments were for
- Food & beverage$2,607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $545 |
| AbbVie | 29 | $490 |
| Amgen | 9 | $160 |
| Novartis | 9 | $160 |
| Novo Nordisk | 8 | $156 |
| Merck | 6 | $123 |
| Abbott | 5 | $99 |
| Johnson & Johnson | 5 | $85 |
| Intra-sana Laboratories | 3 | $76 |
| Exact Sciences | 4 | $69 |
| Dexcom, Inc. | 2 | $67 |
| Pfizer | 3 | $62 |
| Lilly USA, LLC | 3 | $56 |
| Bayer | 4 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Boehringer Ingelheim | 3 | $52 |
| Corcept Therapeutics | 2 | $48 |
| Renalytix AI, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| GSK | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Stryker | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,607 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 68 | $73,942 |
| JardianceEmpagliflozin | 57 | $51,535 |
| FarxigaDapagliflozin Propanediol | 42 | $31,538 |
| EliquisApixaban | 30 | $29,909 |
| TrulicityDulaglutide | 15 | $16,853 |
| OzempicSemaglutide | 18 | $16,661 |
| LinzessLinaclotide | 23 | $16,566 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $15,442 |
| Repatha SureclickEvolocumab | 11 | $11,614 |
| MyrbetriqMirabegron | 15 | $9,392 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,298 |
| JanuviaSitagliptin Phosphate | 11 | $8,474 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 94 | $2,837 |
| Pregabalin | 18 | $2,227 |
| Olmesartan Medoxomil | 18 | $1,455 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $56 | $90,79583 claims |
| Boehringer IngelheimJardiance | $52 | $51,53557 claims |
| AstraZenecaFarxiga | $545 | $31,53842 claims |
| PfizerEliquis | $62 | $29,90930 claims |
| Novo NordiskOzempic | $156 | $16,66118 claims |
| AbbVieLinzess | $490 | $16,56623 claims |
| GSKTrelegy Ellipta | $27 | $15,44224 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $9,39215 claims |
| MerckJanuvia | $123 | $8,47411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,248 family providers in South Carolina.
Other family in Manning
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.